Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Amgen Inc. (AMGN)

-NasdaqGS
153.26 Down 1.73(1.12%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:154.99
Open:155.15
Bid:153.12 x 100
Ask:153.45 x 500
1y Target Est:179.47
Beta:0.63
Earnings Date:Jul 27 - Jul 31 (Est.)
Day's Range:153.01 - 155.57
52wk Range:114.93 - 173.60
Volume:2,120,917
Avg Vol (3m):3,185,840
Market Cap:116.53B
P/E (ttm):20.69
EPS (ttm):7.41
Div & Yield:3.16 (2.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNDown 1.12%116.53B
JNJDown 0.03%272.98B
NVSUp 1.30%241.55B
TEVAUp 1.00%52.20B

Key Statistics

Forward P/E (1 yr):14.51
P/S (ttm):5.73
Ex-Dividend Date:12-May-15

Analysts

Annual EPS Est (Dec-15) :9.58
Quarterly EPS Est (Jun-15) :2.41
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback